134
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

LncRNA JPX contributes to Treg/Th17 imbalance in allergic rhinitis via targeting the miR-378g/CCL5 axis

, , , &
Pages 519-524 | Received 18 Sep 2021, Accepted 12 Mar 2022, Published online: 06 Apr 2022

References

  • Greiner AN, Hellings PW, Rotiroti G, et al. Allergic rhinitis. Lancet. 2011;378(9809):2112–2122.
  • Kakli HA, Riley TD. Allergic rhinitis. Prim Care. 2016;43(3):465–475.
  • Skoner DP. Complications of allergic rhinitis. J Allergy Clin Immunol. 2000;105(6 Pt 2):S605–S609.
  • Bernstein DI, Schwartz G, Bernstein JA. Allergic rhinitis: mechanisms and treatment. Immunol Allergy Clin North Am. 2016;36(2):261–278.
  • Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol. 2001;108(1 Suppl):S2–S8.
  • Numminen J. Allergic rhinitis. Duodecim. 2017;133(5):473–478.
  • Sur DK, Plesa ML. Treatment of allergic rhinitis. Am Fam Physician. 2015;92(1111):985–992.
  • Wang YH, Liu YJ. The IL-17 cytokine family and their role in allergic inflammation. Curr Opin Immunol. 2008;20(6):697–702.
  • Shi H, Chi H. Metabolic control of Treg cell stability, plasticity, and tissue-specific heterogeneity. Front Immunol. 2019;10:2716.
  • Gagliani N, Amezcua Vesely MC, Iseppon A, et al. Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation. Nature. 2015;523(7559):221–225.
  • Lee GR. The balance of Th17 versus Treg cells in autoimmunity. IJMS. 2018;19(3):730.
  • Esensten JH, Muller YD, Bluestone JA, et al. Regulatory T-cell therapy for autoimmune and autoinflammatory diseases: the next frontier. J Allergy Clin Immunol. 2018;142(6):1710–1718.
  • Huang X, Chen Y, Zhang F, et al. Peripheral Th17/treg cell-mediated immunity imbalance in allergic rhinitis patients. Braz J Otorhinolaryngol. 2014;80(2):152–155.
  • Liao K, Xu J, Yang W, et al. The research progress of LncRNA involved in the regulation of inflammatory diseases. Mol Immunol. 2018;101:182–188.
  • Mathy NW, Chen XM. Long non-coding RNAs (lncRNAs) and their transcriptional control of inflammatory responses. J Biol Chem. 2017;292(30):12375–12382.
  • Zhu X, Wang X, Wang Y, et al. Exosomal long non-coding RNA GAS5 suppresses Th1 differentiation and promotes Th2 differentiation via downregulating EZH2 and T-bet in allergic rhinitis. Mol Immunol. 2020;118:30–39.
  • Qian X, Shi S, Zhang G. Long non-coding RNA antisense non-coding RNA in the INK4 locus expression correlates with increased disease risk, severity, and inflammation of allergic rhinitis. Medicine. 2019;98(20):e15247.
  • Yue L, Yin X, Hao F, et al. Long noncoding RNA Linc00632 inhibits interleukin-13-Induced inflammatory cytokine and mucus production in nasal epithelial cells. J Innate Immun. 2020;12(1):116–128.
  • Gál Z, Gézsi A, Semsei ÁF, et al. Investigation of circulating lncRNAs as potential biomarkers in chronic respiratory diseases. J Transl Med. 2020;18(1):422.
  • Deng G, Song X, Fujimoto S, et al. Foxp3 post-translational modifications and Treg suppressive activity. Front Immunol. 2019;10:2486.
  • Sun X, Cui Y, Feng H, et al. TGF-β signaling controls Foxp3 methylation and Treg cell differentiation by modulating Uhrf1 activity. J Exp Med. 2019;216(12):2819–2837.
  • Kanamori M, Nakatsukasa H, Okada M, et al. Induced regulatory T cells: their development, stability, and applications. Trends Immunol. 2016;37(11):803–811.
  • Ciofani M, Madar A, Galan C, et al. A validated regulatory network for Th17 cell specification. Cell. 2012;151(2):289–303.
  • Lee JY, Hall JA, Kroehling L, et al. Serum amyloid a proteins induce pathogenic Th17 cells and promote inflammatory disease. Cell. 2020;183(7):2036–2039.
  • Sun S, Del Rosario BC, Szanto A, et al. Jpx RNA activates xist by evicting CTCF. Cell. 2013;153(7):1537–1551.
  • Li G, Li X, Yuan C, et al. Long non-coding RNA JPX contributes to tumorigenesis by regulating miR-5195-3p/VEGFA in non-small cell lung cancer. Cancer Manag Res. 2021;13:1477–1489.
  • Yang H, Wang G, Liu J, et al. Corrigendum to (LncRNA JPX regulates proliferation and apoptosis of nucleus pulposus cells by targeting the miR-18a-5p/HIF-1α/Hippo-YAP pathway). Biochem Biophys Res Commun. 2021;566:214.
  • Liu W, Yang YJ, An Q. LINC00963 promotes ovarian cancer proliferation, migration and EMT via the miR-378g /CHI3L1 Axis. Cancer Manag Res. 2020;12:463–473.
  • Li W, Zhu Q, Zhang S, et al. HOXC13-AS accelerates cell proliferation and migration in oral squamous cell carcinoma via miR-378g/HOXC13 axis. Oral Oncol. 2020;111:104946.
  • Lin T, Zhou F, Zhou H, et al. MicroRNA-378g enhanced radiosensitivity of NPC cells partially by targeting protein tyrosine phosphatase SHP-1. Int J Radiat Biol. 2015;91(11):859–866.
  • Marques RE, Guabiraba R, Russo RC, et al. Targeting CCL5 in inflammation. Expert Opin Ther Targets. 2013;17(12):1439–1460.
  • Tian Y, Cao Y, Chen R, et al. HMGB1 a box protects neurons by potently inhibiting both microglia and T cell-mediated inflammation in a mouse Parkinson's disease model. Clin Sci. 2020;134(15):2075–2090.
  • Wang X, Lang M, Zhao T, et al. Cancer-FOXP3 directly activated CCL5 to recruit FOXP3+Treg cells in pancreatic ductal adenocarcinoma. Oncogene. 2017;36(21):3048–3058.
  • Zhang RX, Yu SQ, Jiang JZ, et al. Complementary DNA microarray analysis of chemokines and their receptors in allergic rhinitis. J Investig Allergol Clin Immunol. 2007;17(5):329–336.
  • Baraniuk JN. Pathogenesis of allergic rhinitis. J Allergy Clin Immunol. 1997;99(2):S763–S772.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.